Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 03, 2026
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
03:00pm, Wednesday, 18'th Jan 2023 Benzinga
Upgrades
According to Citigroup, the prior rating for Pegasystems Inc (NASDAQ:PEGA) was changed from Neutral to Buy. In the third quarter, Pegasystems showed an EPS of $0.34, compared to $0.40 from th
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
01:50pm, Wednesday, 18'th Jan 2023 Zacks Investment Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
11:20am, Monday, 16'th Jan 2023 Zacks Investment Research
Sector ETF report for FBT
Here's How Much You'd Have If You Invested $1000 in Exact Sciences a Decade Ago
01:30pm, Friday, 13'th Jan 2023 Zacks Investment Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
The Zacks Analyst Blog Highlights Jinko Solar, American Airlines and Exact Sciences
10:00am, Friday, 13'th Jan 2023 Zacks Investment Research
Jinko Solar, American Airlines and Exact Sciences are included in this Analyst Blog.
Exact Sciences (EXAS) Outpaces Stock Market Gains: What You Should Know
11:00pm, Thursday, 12'th Jan 2023 Zacks Investment Research
Exact Sciences (EXAS) closed at $68.54 in the latest trading session, marking a +1.99% move from the prior day.
3 Top Stocks Already up More Than 20% In 2023
07:27pm, Thursday, 12'th Jan 2023 Zacks Investment Research
While inflation remains the market's primary concern, these three stocks have gotten off to a great start in 2023, already up more than 20% year-to-date. Can the strength continue? Their earnings outl
3 Top Stocks Already up More Than 20% In 2023
03:48pm, Thursday, 12'th Jan 2023
While inflation remains the market's primary concern, these three stocks have gotten off to a great start in 2023, already up more than 20% year-to-date. Can the strength continue?
Is Exact Sciences a Buy?
01:45pm, Thursday, 12'th Jan 2023 The Motley Fool
The company's fast-growing business has loads of potential, but it may not be suitable for all investors.
Should iShares Morningstar SmallCap ETF (ISCB) Be on Your Investing Radar?
11:20am, Thursday, 12'th Jan 2023 Zacks Investment Research
Style Box ETF report for ISCB
Zacks Market Edge Highlights: EXAS, ZM, TSLA, ABBV, ZOM
10:00am, Thursday, 12'th Jan 2023 Zacks Investment Research
EXAS, ZM, TSLA, ABBV, ZOM have been highlighted in this Market Edge article.
Is Exact Sciences a Buy?
08:45am, Thursday, 12'th Jan 2023
The company's fast-growing business has loads of potential, but it may not be suitable for all investors.
The Stocks Behind 2022's Popular ETFs
09:01pm, Wednesday, 11'th Jan 2023 Zacks Investment Research
What stocks do popular ETF managers like Cathie Wood own in their portfolios?
Exact Sciences Up 25% YTD: Here Is What To Expect In 2023
04:13pm, Wednesday, 11'th Jan 2023
Despite its price surge, EXAS's valuation remains aligned with industry averages. EXAS has one of the clearest profitability paths in a market characterized by heavy losses stemming from aggressive gr
Here's Why Investors Should Buy Exact Sciences (EXAS) Stock
03:53pm, Wednesday, 11'th Jan 2023 Zacks Investment Research
Investors are optimistic about Exact Sciences (EXAS) on continued strength across the Screening and Precision Oncology businesses.
